STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 96 filers reported holding STOKE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,353,732 | -40.8% | 851,201 | +59.7% | 0.12% | -31.6% |
| Q2 2023 | $5,664,514 | +12.7% | 532,880 | -11.7% | 0.17% | +13.7% |
| Q1 2023 | $5,027,355 | -1.0% | 603,524 | +9.7% | 0.15% | -1.3% |
| Q4 2022 | $5,078,521 | +52.7% | 550,219 | +112.4% | 0.16% | +42.2% |
| Q3 2022 | $3,326,000 | +26.8% | 259,014 | +30.4% | 0.11% | +21.1% |
| Q2 2022 | $2,624,000 | – | 198,621 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 296,822 | $7,551,000 | 1.86% |
| RTW INVESTMENTS, LP | 3,644,248 | $92,710,000 | 1.40% |
| Cormorant Asset Management, LP | 1,278,276 | $32,519,000 | 1.32% |
| Redmile Group, LLC | 2,381,958 | $60,597,000 | 1.06% |
| HighVista Strategies LLC | 47,594 | $1,211,000 | 0.80% |
| Birchview Capital, LP | 15,000 | $382,000 | 0.26% |
| GILDER GAGNON HOWE & CO LLC | 1,123,355 | $28,578,000 | 0.15% |
| Artal Group S.A. | 250,000 | $6,360,000 | 0.14% |
| Tekla Capital Management LLC | 99,263 | $2,525,000 | 0.08% |
| Casdin Capital, LLC | 120,000 | $3,053,000 | 0.08% |